Growing community of inventors

Rykkinn, Norway

Kjetil Tasken

Average Co-Inventor Count = 3.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 2

Kjetil TaskenJo Klaveness (3 patents)Kjetil TaskenBirgitte Lygren (2 patents)Kjetil TaskenEllen Ostensen (2 patents)Kjetil TaskenChristoph Driessen (1 patent)Kjetil TaskenFredrik Hellem Schjesvold (1 patent)Kjetil TaskenLudvig Munthe (1 patent)Kjetil TaskenLenka Besse (1 patent)Kjetil TaskenHesso Farhan (1 patent)Kjetil TaskenAndrej Besse (1 patent)Kjetil TaskenSigrid Skanland (1 patent)Kjetil TaskenMariaserena Giliberto (1 patent)Kjetil TaskenEllen ØStensen (0 patent)Kjetil TaskenKjetil Tasken (4 patents)Jo KlavenessJo Klaveness (116 patents)Birgitte LygrenBirgitte Lygren (2 patents)Ellen OstensenEllen Ostensen (2 patents)Christoph DriessenChristoph Driessen (1 patent)Fredrik Hellem SchjesvoldFredrik Hellem Schjesvold (1 patent)Ludvig MuntheLudvig Munthe (1 patent)Lenka BesseLenka Besse (1 patent)Hesso FarhanHesso Farhan (1 patent)Andrej BesseAndrej Besse (1 patent)Sigrid SkanlandSigrid Skanland (1 patent)Mariaserena GilibertoMariaserena Giliberto (1 patent)Ellen ØStensenEllen ØStensen (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Universitetet I Oslo (4 from 33 patents)


4 patents:

1. 12465607 - ALK inhibitors for treatment of ALK-negative cancer and plasma cell-mediated diseases

2. 9951033 - Tertiary amines for use in the treatment of cardiac disorders

3. 9585880 - Cyclic amino compounds for use in the treatment of cardiac disorders

4. 9556111 - Tertiary amines for use in the treatment of cardiac disorders

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/6/2025
Loading…